Microbiology and visual outcome of bleb-associated endophthalmitis

Ocul Immunol Inflamm. 2010 Apr;18(2):121-6. doi: 10.3109/09273940903370730.

Abstract

Purpose: To identify the microbiological spectrum and visual outcome of bleb-associated endophthalmitis.

Methods: The medical records of patients treated for bleb-associated endophthalmitis were reviewed.

Results: Seventy-five patients were identified. Vitreous cultures were positive in 48 (64%) patients. The most common isolates were Streptococcus species in 24 (50%) eyes, gram-negative bacteria in 10 (20.8%) eyes, and Staphylococcus epidermidis in 7 (14.6%) eyes. Good visual outcome was achieved in 33 (44%) patients. On univariate analysis, shorter interval from onset of symptoms and treatment (p = .005), better initial visual acuity (p = .004), clear cornea at presentation (p = .048), isolation of less virulent organisms (p < .001), and absence of diabetes mellitus (p = .048) were significant positive predictors for good visual outcome.

Conclusions: Bleb-associated endophthalmitis is associated with severe visual impairment. Clinical features associated with better visual outcome include early presentation, better presenting visual acuity, clear cornea at presentation, culture of a less virulent organism, and absence of diabetes mellitus.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Anti-Bacterial Agents / therapeutic use
  • Bacteria / classification*
  • Bacteria / isolation & purification
  • Blister / drug therapy
  • Blister / microbiology*
  • Blister / physiopathology
  • Child
  • Child, Preschool
  • Endophthalmitis / drug therapy
  • Endophthalmitis / microbiology*
  • Endophthalmitis / physiopathology
  • Eye Infections, Bacterial / drug therapy
  • Eye Infections, Bacterial / microbiology*
  • Eye Infections, Bacterial / physiopathology
  • Female
  • Glaucoma / surgery
  • Humans
  • Infant
  • Male
  • Middle Aged
  • Retrospective Studies
  • Saudi Arabia
  • Treatment Outcome
  • Visual Acuity*
  • Young Adult

Substances

  • Anti-Bacterial Agents